Plexāā | Creators of BLOOM⁴³ advanced its positioning in pre-surgical digital health this week, highlighting new educational, clinical, and brand-building initiatives around its BLOOM⁴³ Prehab™ platform. The company continues to focus on women preparing for breast and oncology-related surgery, emphasizing prehabilitation as a critical but under-served phase of care.
Plexāā is promoting a free Prehab webinar scheduled for May 21, 2026, led by founder and plastic surgeon Dr. Saahil Mehta and patient champions who are breast cancer survivors. The session will address nutrition, sleep, movement, mental wellbeing, and real patient experiences, aiming to deepen engagement with the breast surgery and cancer communities.
The firm is also foregrounding BLOOM⁴³’s strategic focus on the pre-operative gap, drawing on Dr. Mehta’s commentary on the RadChat podcast about patients’ need for structured preparation. Management positions the platform as integrated into clinical pathways rather than a standalone wellness tool, targeting value-based care and outcome improvement.
Content development remains clinically led, with Plexāā spotlighting advanced plastic surgery nurse Laura Jane Powell for shaping app materials across the surgery journey. Her contributions span practical topics, such as post-surgery bra selection, and emotional support around body image and recovery, which could enhance user engagement and provider confidence.
Plexāā is increasing clinician outreach by participating in The Aesthetic Society’s Aesthetic Meet 2026, where Mehta and U.S. patient champion Nichole Wenderlich Owens plan one-on-one meetings. This follows visibility at specialty conferences including the Cedars-Sinai LA Symposium in Plastic and Reconstructive Surgery and The American Society of Breast Surgeons Annual Meeting.
Brand validation strengthened as BLOOM⁴³ Prehab™ won a 2026 MedTech Breakthrough Award for Best Overall Women’s Health Solution and a Red Dot Design Award. The company was also featured in the AONN+ Midyear Conference Innovation Showcase, signaling growing recognition in oncology navigation networks and supporting future partnership and reimbursement discussions.
Collectively, these awards, clinical collaborations, and education initiatives suggest Plexāā is consolidating its niche in perioperative femtech and prehabilitation. While financial metrics were not disclosed, the week underscored rising ecosystem engagement and external validation that could support longer-term commercialization and provider adoption.
